PMID- 12825178 OWN - NLM STAT- MEDLINE DCOM- 20030813 LR - 20061115 IS - 0022-1899 (Print) IS - 0022-1899 (Linking) VI - 188 IP - 1 DP - 2003 Jul 1 TI - Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway. PG - 108-13 AB - We tested whether polymorphic membrane proteins (PMPs) of Chlamydia pneumoniae might play a role in triggering an inflammatory response in human endothelial cells. Of 15 purified, recombinant chlamydial PMPs tested, 2 (PMP 20 and PMP 21) dose-dependently increased the production of the inflammatory mediators interleukin (IL)-6 and monocyte chemoattractant protein-1 (MCP-1), in cultured human endothelial cells; production of IL-8 was also increased. When endothelial cells were infected by live C. pneumoniae, an increase in the production of IL-6, IL-8, and MCP-1 was seen. We used adenovirus-induced overexpression of IkappaBalpha-an inhibitor of nuclear factor (NF)-kappaB-to demonstrate that PMP 20 and PMP 21 increase the production of IL-6 and MCP-1 in human endothelial cells by activation of the NF-kappaB pathway, because, in cells overexpressing IkappaBalpha, treatment with the respective PMP did not result in increased production of IL-6 and MCP-1. Thus, C. pneumoniae could, by interactions of its PMPs with the endothelium, contribute to the process of vascular injury during the development and progression of atherosclerotic lesions. FAU - Niessner, Alexander AU - Niessner A AD - Department of Internal Medicine II, University of Vienna, Vienna, Austria. FAU - Kaun, Christoph AU - Kaun C FAU - Zorn, Gerlinde AU - Zorn G FAU - Speidl, Walter AU - Speidl W FAU - Turel, Zeynep AU - Turel Z FAU - Christiansen, Gunna AU - Christiansen G FAU - Pedersen, Anna-Sofie AU - Pedersen AS FAU - Birkelund, Svend AU - Birkelund S FAU - Simon, Susan AU - Simon S FAU - Georgopoulos, Apostolos AU - Georgopoulos A FAU - Graninger, Wolfgang AU - Graninger W FAU - de Martin, Rainer AU - de Martin R FAU - Lipp, Joachim AU - Lipp J FAU - Binder, Bernd R AU - Binder BR FAU - Maurer, Gerald AU - Maurer G FAU - Huber, Kurt AU - Huber K FAU - Wojta, Johann AU - Wojta J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20030612 PL - United States TA - J Infect Dis JT - The Journal of infectious diseases JID - 0413675 RN - 0 (Bacterial Outer Membrane Proteins) RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (NF-kappa B) SB - IM MH - Bacterial Outer Membrane Proteins/*pharmacology MH - Cells, Cultured MH - Chemokine CCL2/biosynthesis MH - Chlamydophila pneumoniae/*chemistry MH - Cytokines/*biosynthesis MH - Endothelium, Vascular/*drug effects/*metabolism MH - Humans MH - Inflammation/metabolism MH - Interleukin-6/biosynthesis MH - Interleukin-8/biosynthesis MH - NF-kappa B/*metabolism MH - Signal Transduction/drug effects MH - Umbilical Veins/cytology EDAT- 2003/06/26 05:00 MHDA- 2003/08/14 05:00 CRDT- 2003/06/26 05:00 PHST- 2002/10/22 00:00 [received] PHST- 2003/02/12 00:00 [accepted] PHST- 2003/06/26 05:00 [pubmed] PHST- 2003/08/14 05:00 [medline] PHST- 2003/06/26 05:00 [entrez] AID - JID30236 [pii] AID - 10.1086/375827 [doi] PST - ppublish SO - J Infect Dis. 2003 Jul 1;188(1):108-13. doi: 10.1086/375827. Epub 2003 Jun 12.